https://www.selleckchem.com/pr....oducts/etomoxir-na-s
The patient global assessment of disease activity (PGA) is the major limiting factor to Boolean remission in patients with established rheumatoid arthritis (RA). Here, we investigated the limiting variables to disease remission in patients with early RA treated with conventional synthetic disease modifying anti-rheumatic drugs, also in relation to autoantibody status. Data were retrieved from 535 early RA patients (12 months of symptoms) with an observation period of 6-12 months upon initiation of therapy with methotrexate
Like
Comment
Share
